6533b7cffe1ef96bd1258501
RESEARCH PRODUCT
Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): study protocol for a randomized controlled trial.
Ab CavalcantiO BerwangerÉA SuzumuraMb AmatoFs TalloAc RezendeMm TellesE RomanoHp GuimarãesMm RegengaLn TakahashiRp OliveiraVo CarvalhoFa Díaz QuijanoCr CarvalhoO BerwangerAa KodamaGf RibeiroMo AbreuIm OliveiraG GuyattN FergusonS WalterMo VasconcelosVj SegundoÍL FerrazRs SilvaW De Oliveira FilhoNb SilvaC HeirelRr TakataniJa NetoJc NetoSd AlmeidaG ChamyGj NetoAp DiasRr SilvaRc TavaresMl SouzaJc DecioCm LimaFf NetoKr OliveiraPp DiasAl BrandãoJe Jr RamosPt VasconcelosDg FlôresGr FilhoIg AndradeA MartinezGg FrançaLl MonteiroEi CorreiaW RibeiroAj PereiraW AndradePa LeiteGr FilhoDg FlôresJe FetoMa HolandaFf AmorimSb MargalhoSm Jr DominguesCs FerreiraCm FerreiraLa RabeloJn DuarteFb LimaIa KawaguchiJa NetoMo MaiaFg CorreaRa RibeiroE CaserCl MoreiraA MarcilinoJg FalcãoKr JesusL TcherniakoviskVg DutraMm ThompsonC PirasJ. Jr GiubertiAs SilvaJr SantosJl PotratzLn PaulaGg BoziBc GomesPf VassalloE RochaMh LimaA. F FerreiraF GonçalvesSa PereiraMs NobregaCr CaixetaAp MoraesAg CarvalhoJd AlvesFb CarvalhoFb MoreiraCm StarlingWa CoutoWs BitencourtSg SilvaLr FelizardoFj NascimentoD SantosCc ZantaMf MartinsSa NavesFd SilvaG. Jr LaubeEl GalvãoMf SousaMm SouzaFl CarvalhoRr BergoCm RezendeEy TamazatoSc Jr SaratPs AlmeidaAg GorskiM MatsuiEe NetoSh NomotoZb LimaAs InagakiFs GilMf AraújoAe OliveiraTa CorreaA MendonçaH ReisSr CarneiroLr RegoAf CunhaWf BarraM CarneiroRa BatistaKk ZoghbiNj MachadoR FerreiraP ApoenaRm LeãoEr MartinsMe OliveiraI OdirW KleberD TavaresEr MartinsMe AraújoYn BrilhanteDc TavaresW KleberWl CarvalhoGf WinvelerAc FilhoRa CavalcantiCm GrionAt ReisJ FesttiFm GimenezCm GrionAs LarangeiraLt CardosoTs MezzarobaIa KaussPa DuarteTc TozoP PeliserA GermanoSj GurgelSr SilvaCm KurodaA HerekSs YamadaPm SchiavettoN WysockiRr MatsubaraJa Jr SalesMp LaprovitaFm PenaA SáA ViannaJc VerdealGa MartinsDr SalgadoAm CoelhoM CoelhoAs MorongRm PoquiriquiAp FerreiraDn LucenaNf MarinoMa MoreiraCc UrataniMa SeverinoPn SilvaLg MedeirosFg FilhoDm GuimarãesVm RezendeRc CarbonellRs TrindadeJa PellegriniMm BoniattiMc SantosR BoldoVm OliveiraVm CorrêaW NedelC TeixeiraRp OliveiraF SchaichL TagliariA SaviLf SchulzJg MaccariRp OliveiraC TeixeiraGm SeegerRb FoerngesMm RiederDa BeckerFp BroiloP SchwarzA AlencastroP BertoF BackesJa PellegriniFs DiasC BlattnerEt MartinsNc ScagliaSr VieiraKf PradoL FialkowC FrankeDf VieiraRb MoraesP SchwarzLs MarquesJl HopfIc WawrzeniakTh RechRb AlbuquerqueMo GuerreiroLo TeixeiraPl MacedoMp BainyEv FerreiraMa MartinsLa AndradeFo MachadoAc BurigoM PincelliL KretzerIs MaiaRb CordeiroG WestphalAs CramerMm DadamPo BarbosaM CaldeiraG WestphalCo BrilengerMb HornerGl OliveiraBc GerminianiC TeixeiraR DuarteMg AssefD RossoR BigolinR VanzuitaMa MartinsLf PradoV OliveiraDl ReisMo MoraisRs BastosHs SantanaAo SilvaLa CacauMs AlmeidaHs CanavessiEe NogueiraCl PaviaDl ReisJf AraujoJa LiraEc NienstedtTc SmithE RomanoM RomanoMm RegengaBarros DAf CostaL TakahashiV WerneckJ FarranLa HenriquesC MiuraRd LopesLs VendrameHp GuimarãesP SandriMs GalassiCr CarvalhoP AmatoC. Jr ToufenRr SantiagoAs HirotaM ParkLc AzevedoLm MalbouisonMc CostaL TaniguchiCe PompílioC BaruzziAh AndradeEe TairaB TainoCs OliveiraAc SilvaA ÍSolaE RezendeRg RodriguesVp RangelS LuzziIw GiacomassiAp Jr NassarAr SouzaL RahalAl NunesF GianniniB MenescalJe MoraisD ToledoRd MorschT MerluzziDs AmorimAc BastosPl SantosSf SilvaRc GallegoGd SantosM TucciRt CostaLs SantosSe DemarzoGp SchettinoLc AzevedoVc SuzukiAc PatrocinioMl MartinsDb PassosSb CappiI. Jr GonçalvesMc BorgesW LovatoMv TavaresD MoralesLa MachadoFc TorresTm GomesRb CerantolaA GóisT MarracciniK MargaridaE CavalcanteFr MachadoBf MazzaHb SantanaVm MendezPa XavierMv RabeloFr SchievanoWa PintoRs FranciscoEm FerreiraDc SilvaRg ArduiniJr AldrighiAf AmaroKa CondeCa PereiraE TarkieltaubWr OliverEg GuadalupePs AcerbiCi TomizukaTa OliveiraNn GehaGc MecattiMz PiovesanMc SalomãoMs MorenoVn OrsattiW MirandaA RayA GuerraMl FilhoFh Jr FerreiraEv FilhoRa CanziAf GiubertiMc GarcezAd SalaEo SuguitaniP KazueLr OliveiraRm InfantiniFr CarvalhoLc AndradeHp GuimarãesTm SantosCv CarmonaLc FigueiredoA FalcãoD DragosavakWn FilhoMc LunardiR LagoC GattiTm ChiassoGo SantosAc SilvaAc AraujoIb OrnellasVm VieiraLa HajjarAc FigueiredoVm VieiraB DamascenoA HinestrosaFa Diaz QuijanoAndrea CortegianiSanti Maurizio Rainerisubject
Research designARDSmedicine.medical_specialtyTime FactorsVentilator-Induced Lung InjuryAlveolar recruitmentTreatment outcomeRandomizedMedicine (miscellaneous)Settore MED/41 - AnestesiologiaHospital mortalitylaw.inventionPositive-Pressure RespirationStudy ProtocolMechanical ventilationClinical trialsRandomized controlled trialClinical ProtocolslawMedicineHumansPharmacology (medical)Hospital MortalityPEEPProtocol (science)Respiratory Distress SyndromeAcute respiratory distress syndromebusiness.industryrespiratory systemLength of Staymedicine.diseaseClinical trialPulmonary AlveoliARDS; Alveolar recruitment; PEEPIntensive Care UnitsTreatment OutcomeMulticenter studyBarotraumaResearch DesignPhysical therapyARDSbusinessBrazildescription
Abstract Background Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). Methods/Design ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with ARDS compared to conventional treatment (ARDSNet strategy). We will enroll adult patients with ARDS of less than 72 h duration. The intervention group will receive an alveolar recruitment maneuver, with stepwise increases of PEEP achieving 45 cmH2O and peak pressure of 60 cmH2O, followed by ventilation with optimal PEEP titrated according to the static compliance of the respiratory system. In the control group, mechanical ventilation will follow a conventional protocol (ARDSNet). In both groups, we will use controlled volume mode with low tidal volumes (4 to 6 mL/kg of predicted body weight) and targeting plateau pressure ≤30 cmH2O. The primary outcome is 28-day survival, and the secondary outcomes are: length of ICU stay; length of hospital stay; pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days; mechanical ventilation-free days from days 1 to 28; ICU, in-hospital, and 6-month survival. ART is an event-guided trial planned to last until 520 events (deaths within 28 days) are observed. These events allow detection of a hazard ratio of 0.75, with 90% power and two-tailed type I error of 5%. All analysis will follow the intention-to-treat principle. Discussion If the ART strategy with maximum recruitment and PEEP titration improves 28-day survival, this will represent a notable advance to the care of ARDS patients. Conversely, if the ART strategy is similar or inferior to the current evidence-based strategy (ARDSNet), this should also change current practice as many institutions routinely employ recruitment maneuvers and set PEEP levels according to some titration method. Trial registration ClinicalTrials.gov Identifier: NCT01374022
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2012-02-23 | Trials |